Frontiers | Development and Application of a Novel Rapid and Throughput Method for Broad-Spectrum Anti-Foodborne Norovirus Antibody Testing
Vaxart stock rises as COVID pill vaccine shows response, safety in trial | Seeking Alpha
avir20170630_10k.htm
Vaxart stock slips more than 8% as Q3 expenses jump, cash position deteriorates | Seeking Alpha
The next generation Covid-19 vaccines seeking a slice of the market | Financial Times
Vaxart, Inc. – SEC Filing
SARS-CoV-2 Vaccine Development: An Overview and Perspectives | ACS Pharmacology & Translational Science
COVID-19 Vaccines: Global Health Issues
Enabling Rapid Response and Sustained Capability with Medical Countermeasures to Mitigate Risk of Emerging Infectious Diseases:
Vaccines | Free Full-Text | COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform
avir20170630_10k.htm
COVID-19 tracker: Omicron booster nods expected Wednesday
Vaxart appoints first general counsel | Corporate Secretary
Bioengineering | Free Full-Text | COVID-19 Vaccines: An Updated Overview of Different Platforms
Conversation with Albert Bourla, CEO of Pfizer | chief executive officer, Pfizer | Conversation with Albert Bourla, CEO of Pfizer A conversation with Pfizer Chief Executive Officer Albert Bourla | By World
Vaxart Has Developed the First Oral Investigational COVID-19 Vaccine
